MedExecWomen 2019
Tuesday, April 2, 2019 | New York City
Laurie Halloran – Event Master of Ceremonies
7:00 – 8:00 AM Breakfast & Networking
8:00 – 8:30 AM Welcome & Introduction to MedExecWomen–Rupa Basu
8:30 – 9:15 AM A Patient’s Story: Kristina Sheridan (Department Head, Enterprise Transition Planning and Execution, MITRE Corporation), Kate Sheridan
Kristina is an expert in patient empowerment. As a principal investigator for MITRE, she identifies and evaluates methods to empower patients with chronic illnesses to better manage their care and to fully engage with providers to improve their health outcomes. Her long struggle with her daughter’s personal health crisis with Lyme disease and journey forged her role as patient advocate for her daughter.
9:15 – 10:15 AM Panel 1: The Lifecycle of Funding from A to Z
How to raise your first round of funding? The last several years have been challenging for medtech. Shifting climates for public and private reimbursement, and a weak appetite for medtech investments within the VC community have made it difficult for early-stage companies to secure funding.
Moderator - Karen Zaderej, President, CEO and Chairman of the Board at AxoGen, Inc.
Panelists
Maria Palasis, CEO, Lyra Therapeutics
Nancy Briefs, Co-Founder, President & CEO of AltrixBio, Inc.
Joyce Erony, Managing Partner, Amzak Health
Darshana Zaveri, Managing Partner, Catalyst Health Ventures
10:15 – 10:30 AM Break
10:30 – 11:30 AM Panel 2: The Value Framework and Reimbursement Strategy
How can a company maximize its investments by spending on reimbursement activities that drive the most value? This panel will review the process of defining key success factors in global market access.
Moderator – Meghna Eichelberger, Principal, Boston Consulting Group
Panelists
Martha Shadan, President and CEO of Miach Orthopaedics
Kristen Hedstrom, Vice President, Vice President, Payer Relations, Boston Scientific
Stephanie Wimmer, Senior Director, Global Reimbursement, Medtronic
Don May, Executive Vice President, Payment and Healthcare Delivery Policy, AdvaMed
11:30 AM – 12:30 PM Lunch
12:30 – 1:15 PM Executive Interview: Celine Martin (Global President of Digital Surgery at Johnson & Johnson and Ethicon)
Interviewer - Maria Shepherd, President & CEO, Medi-Vantage
1:15 – 1:45 Liz Bywater, Slowing Down to Speed Up
1:45 - 2:30 Panel 3: How to Innovate in a Fortune 500 Medtech Company
Moderator – Mary Beth Moynihan, SVP, Corporate Marketing and Market Access, Boston Scientific
Panelists
Dave Knapp, VP, R&D, Boston Scientific
Tracy Accardi, Global Vice President of Research & Development, Hologic
Tracy McNeal, President of Diagnostics and Digital Health, Ximedica
Helen Routh, Board Chair, Ultromics, former SVP Strategy & Innovation, Head of Integrated Solutions, Philips
2:30 – 3:00 PM Break
3:00 – 3:45 PM Panel 4: Solutions to use Social Media to Reach a Healthcare Audience
How do we create and implement communication strategies that tell the unique story of a medtech organization for maximum impact with target audiences? How do we translate science into compelling language and memorable visuals to portray the possibilities of innovation?
Moderator - Stacey Holifield, Founder @ Levitate / Strategic Communications Agency
Panelists
Rupa Basu, Vice President of Marketing, Biotronik
Kasia Hein Peters, VP Marketing, Terumo BCT
Kelly Leadem, Vice President, Global Corporate Communications at Boston
Brian Loew – CEO, Inspire
3:45-4:30 PM Panel 5: How to become a Board Member
Moderator – Leslie Loveless, CEO & Partner, Slone Partners
Panelists
Martha Shadan, President and CEO of Miach Orthopaedics
Nancy Briefs, Co-Founder, President & CEO of AltrixBio, Inc.
Cheryl Blanchard, Board Director, Anika Therapeutics, President and CEO, Microchips
Faith Charles, Partner, Corporate Transaction & Securities, Thompson Hines, LLP
4:30 – 5:00 End of day Keynote: Carolyn Buck Luce
Carolyn is the co-founder and Managing Partner of Imaginal Labs LLC, dedicated to helping courageous leaders make the difference they dream of. Carolyn stands for women’s transformational journey to lead the way in bringing a new kind of power to the business of humanity.